Stock Market News

Eli Lilly to buy psychedelics maker AtaiBeckley for $2.8 billion as experimental treatments gain traction

wcc wcc
Jul 16, 2026 - 11:10
0 1
The deal for AtaiBeckley gives Lilly access to experimental drugs based on DMT and MDMA.

Previous Article

Wall Street's profit boom has Europe ripping up its banking rulebook

Next Article

UnitedHealth blows past estimates, hikes earnings outlook as it reins in costs

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0
wcc
wcc

Related Posts

Chicago Atlantic Real Estate Finance (REFI) Agrees to Merge Into Chicago Atlantic BDC

Chicago Atlantic Real Estate Finance (REFI) Agrees t...

wcc
Jul 16, 2026
0
1
Blackstone Mortgage Trust (BXMT) Holds Its Dividend Steady as a Hotel-Loan Charge Hits Earnings

Blackstone Mortgage Trust (BXMT) Holds Its Dividend ...

wcc
Jul 16, 2026
0
1
Raymond James Maintains Market Perform Rating on Bumble (BMBL) Stock

Raymond James Maintains Market Perform Rating on Bum...

wcc
Jul 16, 2026
0
1
What to Expect From Arista Networks' Q2 2026 Earnings Report

What to Expect From Arista Networks' Q2 2026 Earning...

wcc
Jul 16, 2026
0
1
Citizens Keeps an $11 Price Target on Franklin BSP Realty Trust (FBRT) Despite Short-Term Earnings Pressure

Citizens Keeps an $11 Price Target on Franklin BSP R...

wcc
Jul 16, 2026
0
1
Northland Begins Coverage of Granite Ridge Resources (GRNT) Stock

Northland Begins Coverage of Granite Ridge Resources...

wcc
Jul 16, 2026
0
1

Comments (0)

User